Related references
Note: Only part of the references are listed.Evolution of prognostic factors in hepatocellular carcinoma in Japan
K. Nouso et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Review article: the management of hepatocellular carcinoma
R. Cabrera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib
Violaine Ozenne et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Advanced Hepatocellular Carcinoma: Which Staging Systems Best Predict Prognosis?
Fidel-David Huitzil-Melendez et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Alejandro Forner et al.
SEMINARS IN LIVER DISEASE (2010)
Phase 2 Open-label Study of Single-agent Sorafenib in Treating Advanced Hepatocellular Carcinoma in a Hepatitis B-endemic Asian Population
Thomas Yau et al.
CANCER (2009)
Safety and Efficacy of Sorafenib in Patients With Advanced Hepatocellular Carcinoma in Consideration of Concomitant Stage of Liver Cirrhosis
Marcus Alexander Wörns et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib in Unresectable Hepatocellular Carcinoma from Mild to Advanced Stage Liver Cirrhosis
Matthias Pinter et al.
ONCOLOGIST (2009)
Review article: pharmacological therapy for hepatocellular carcinoma with sorafenib and other oral agents
M. Chaparro et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival
Chi-Sin Changchien et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase II study of sorafenib in patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Evolving consensus in portal hypertension - Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension
R de Franchis
JOURNAL OF HEPATOLOGY (2005)
Updated treatment approach to hepatocellular carcinoma
JM Llovet
JOURNAL OF GASTROENTEROLOGY (2005)
Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum
A Burroughs et al.
LANCET ONCOLOGY (2004)
Genome-scale profiling of gene expression in hepatocellular carcinoma: Classification, survival prediction, and identification of therapeutic targets
JS Lee et al.
GASTROENTEROLOGY (2004)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference
J Bruix et al.
JOURNAL OF HEPATOLOGY (2001)
Hepatocellular carcinoma in Central Europe: prognostic features and survival
M Schoniger-Hekele et al.
GUT (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
